PRINCE’s prospects: Statins, inflammation, and coronary risk
- 1 June 2001
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 141 (6) , 881-883
- https://doi.org/10.1067/mhj.2001.115298
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial)Published by Oxford University Press (OUP) ,2000
- The evolving role of statins in the management of atherosclerosisJournal of the American College of Cardiology, 1999
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent InstabilityCirculation, 1999
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the MoonNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Hyperlipidemia and Coronary DiseaseCirculation, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994